EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation

Leyuan Wang iD, Jianhui Yang iD, Yang Liu iD, Qi Liu iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71752 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Leyuan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Nanoparticles, Proteolysis, Drug Delivery Systems, Proteins. Die Arbeit nennt 207 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Research Project for Anhui Universities, Key Project for Cultivating Excellent Young Teachers in Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) has fundamentally redefined pharmacological intervention, shifting from classical occupancy‐driven inhibition to event‐driven elimination of undruggable pathogenic proteins, holding great promise for treating various intractable diseases. Although heterobifunctional degraders and molecular glues show immense therapeutic promise, their clinical translation is hindered by pharmacokinetic and pharmacodynamic disconnects, including violation of Lipinski's Rule of Five (Ro5) and autoinhibitory thermodynamics known as the hook effect. Nanoparticle‐based delivery systems offer a feasible solution that goes beyond passive solubilization. This review provides a comprehensive evaluation of advanced nanocarriers as spatiotemporal kinetic orchestrators, highlighting their capacity for active and precise therapeutic applications. In this review, we summarize recent progress in nanoparticle‐based TPD delivery strategies, outlining TPD molecular pathways and diverse nanocarriers for efficient delivery of TPD agents, including liposomes, polymeric nanoparticles, micelles, DNA nanostructures, inorganic nanomaterials, and biological carriers. Furthermore, the mechanisms, targeting strategies, preclinical efficacy, biological barriers, and optimization strategies of these works are detailed. Finally, we propose two solutions, namely localized zero‐order release platforms and engineered living vectors, with the potential to bypass physiological barriers and promote the clinical translation of TPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesProteolysisDrug Delivery SystemsProteinsHumansAnimalsLiposomes

Stichwörter der Autor:innen

lysosome‐targeting chimerananoparticle‐based drug deliveryproteolysis‐targeting chimerastimuli‐responsive nanocarriertargeted protein degradation

Substanzen

ProteinsLiposomes

Autor:innen und Institutionen

  • School of Pharmacy, Anhui Medical University, Hefei, China.
  • State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Functional Polymer Materials Ministry of Education, College of Chemistry, Nankai University, Tianjin, China.

ORCID-Profile: Leyuan Wang, Jianhui Yang, Yang Liu, Qi Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Research Project for Anhui Universities
  • Key Project for Cultivating Excellent Young Teachers in Anhui Province

Zitieren

APA

Wang, L., Yang, J., Liu, Y., & Liu, Q. (2026). Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71752

Vancouver

Wang L, Yang J, Liu Y, Liu Q. Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71752

BibTeX
@article{Wang2026,
  author = {Wang, Leyuan and Yang, Jianhui and Liu, Yang and Liu, Qi},
  title = {Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71752}
}
Kostenlos starten →